One intriguing observation was that patients with seminoma and mGCT often developed T‐cell responses against several MAGE‐A family proteins whereas patients with NSGCTT only exhibited immune responses with specificity for MAGE‐A3. This evidence concerns the gene MAGEA3 and seminoma.